Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
A Promising Experimental Ebola Drug Goes Overlooked
Bloomberg/Businessweek
Mon, 10/20/14 - 08:13 am
ebola virus
Sarepta Therapeutics
AVI-7537
Sarepta +11.7% after hours on positive results for Ebola treatment
Seeking Alpha
Thu, 10/16/14 - 06:45 pm
Sarepta Therapeutics
ebola virus
AVI-6002
AVI-6003
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
The Chairman's Blog
Mon, 10/13/14 - 04:09 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Ebola Drug Stocks React Wildly to Dallas Patient Death
24/7 Wall St
Wed, 10/8/14 - 02:43 pm
ebola virus
Tekmira
Biocryst
Chimerix
Sarepta Therapeutics
Biotechs That Might Benefit From Ebola
Yahoo/Benzinga
Tue, 08/12/14 - 08:29 am
ebola virus
Tekmira Pharmaceuticals
Sarepta Therapeutics
Biocryst
NanoViricides
Sarepta Ready to Provide Ebola Drug if Needed
Barron's
Tue, 08/5/14 - 08:05 am
Sarepta Therapeutics
ebola virus
Stop Squabbling, Mom Tells Troubled Biotech: 'Just Get My Kid the Drug'
Bloomberg/Businessweek
Mon, 07/28/14 - 12:19 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Latest Sarepta Study Update Shows Greater Decline in Walking Ability
TheStreet.com
Thu, 07/10/14 - 08:51 am
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Why Wall Street is Betting Heavily Against Sarepta Therapeutics
Motley Fool
Sun, 06/8/14 - 09:35 am
Sarepta Therapeutics
Sarepta gearing for potential 2015 launch of eteplirsen, says Piper Jaffray
The Fly on the Wall
Thu, 05/22/14 - 11:54 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Motley Fool
Thu, 05/8/14 - 12:26 pm
Sarepta Therapeutics
earnings
Sarepta's Still a Gamble, Even With FDA Reversal
Motley Fool
Fri, 04/25/14 - 08:31 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Sarepta Surges on Optimism Over Muscular Dystrophy Drug
Bloomberg
Mon, 04/21/14 - 10:32 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics on Cusp of Huge Eteplirsen News
TheStreet.com
Tue, 04/8/14 - 05:16 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Prosensa jumps 30% after data from Phase 2 study of DMD drug
The Fly on the Wall
Tue, 03/18/14 - 09:01 am
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
biotech
Sarepta Therapeutics
OncoMed
Vivus
MannKind
Myriad Genetics
Why Sarepta Therapeutics Inc. Might Have a Fighting Chance
Motley Fool
Wed, 03/5/14 - 11:53 am
Sarepta Therapeutics
eteplirsen
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Mon, 02/24/14 - 11:15 am
Spectrum Pharmaceuticals
Dendreon
Achillion
Ziopharm
Intrexon
Arena Pharmaceuticals
Idenix
Synta Pharmaceuticals
Sarepta Therapeutics
Myriad Genetics
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »